
Serinus Biosciences is a biotechnology company focused on revolutionizing drug discovery and clinical translation by harnessing interactome foundation models to target disease pathways through altered protein interactions. Their innovation centers on protein complex-centric approaches to drug development, aiming to create effective medicines that address disease mechanisms at the molecular level. The company is based in New York and emphasizes leveraging advanced AI and biological insights to improve therapeutic outcomes.

Serinus Biosciences is a biotechnology company focused on revolutionizing drug discovery and clinical translation by harnessing interactome foundation models to target disease pathways through altered protein interactions. Their innovation centers on protein complex-centric approaches to drug development, aiming to create effective medicines that address disease mechanisms at the molecular level. The company is based in New York and emphasizes leveraging advanced AI and biological insights to improve therapeutic outcomes.